These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 8883959
1. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Naveilhan P, Neveu I, Baudet C, Funakoshi H, Wion D, Brachet P, Metsis M. Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):259-68. PubMed ID: 8883959 [Abstract] [Full Text] [Related]
2. Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy. Kuo LT, Groves MJ, Scaravilli F, Sugden D, An SF. Neuroscience; 2007 Jun 29; 147(2):491-507. PubMed ID: 17532148 [Abstract] [Full Text] [Related]
3. Expression of mRNAs for neurotrophin receptors in the dorsal root ganglion and spinal cord during development and following peripheral or central axotomy. Ernfors P, Rosario CM, Merlio JP, Grant G, Aldskogius H, Persson H. Brain Res Mol Brain Res; 1993 Mar 29; 17(3-4):217-26. PubMed ID: 8510496 [Abstract] [Full Text] [Related]
4. Effects of aging and axotomy on the expression of neurotrophin receptors in primary sensory neurons. Bergman E, Fundin BT, Ulfhake B. J Comp Neurol; 1999 Aug 02; 410(3):368-86. PubMed ID: 10404406 [Abstract] [Full Text] [Related]
5. Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents. Condorelli DF, Dell'Albani P, Mudò G, Timmusk T, Belluardo N. J Neurochem; 1994 Aug 02; 63(2):509-16. PubMed ID: 7518499 [Abstract] [Full Text] [Related]
6. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. Funakoshi H, Frisén J, Barbany G, Timmusk T, Zachrisson O, Verge VM, Persson H. J Cell Biol; 1993 Oct 02; 123(2):455-65. PubMed ID: 8408225 [Abstract] [Full Text] [Related]
7. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene. Nanes MS, Kuno H, Demay MB, Kurian M, Hendy GN, DeLuca HF, Titus L, Rubin J. Endocrinology; 1994 Mar 02; 134(3):1113-20. PubMed ID: 8119149 [Abstract] [Full Text] [Related]
8. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. Assimakopoulou M, Kondyli M, Gatzounis G, Maraziotis T, Varakis J. BMC Cancer; 2007 Oct 31; 7():202. PubMed ID: 17971243 [Abstract] [Full Text] [Related]
9. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K. Biochemistry; 1995 Jan 10; 34(1):370-7. PubMed ID: 7819220 [Abstract] [Full Text] [Related]
10. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep 10; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. Baudet C, Chevalier G, Chassevent A, Canova C, Filmon R, Larra F, Brachet P, Wion D. J Neurosci Res; 1996 Dec 01; 46(5):540-50. PubMed ID: 8951666 [Abstract] [Full Text] [Related]
12. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H, Kurian SM, Hendy GN, White J, deLuca HF, Evans CO, Nanes MS. Endocrinology; 1994 Jun 01; 134(6):2524-31. PubMed ID: 8194478 [Abstract] [Full Text] [Related]
13. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Veenstra TD, Fahnestock M, Kumar R. Biochemistry; 1998 Apr 28; 37(17):5988-94. PubMed ID: 9558335 [Abstract] [Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice. Bedalov A, Salvatori R, Dodig M, Kapural B, Pavlin D, Kream BE, Clark SH, Woody CO, Rowe DW, Lichtler AC. Biochim Biophys Acta; 1998 Jul 09; 1398(3):285-93. PubMed ID: 9655920 [Abstract] [Full Text] [Related]
17. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element. Uchida M, Ozono K, Pike JW. J Bone Miner Res; 1994 Dec 09; 9(12):1981-7. PubMed ID: 7872065 [Abstract] [Full Text] [Related]
18. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene. Wu Y, Craig TA, Lutz WH, Kumar R. Biochemistry; 1999 Mar 02; 38(9):2654-60. PubMed ID: 10052935 [Abstract] [Full Text] [Related]
19. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y, Pike JW, Koeffler HP. Leuk Res; 1995 Mar 02; 19(3):147-58. PubMed ID: 7700077 [Abstract] [Full Text] [Related]
20. Lesion-induced changes in the expression of ciliary neurotrophic factor and its receptor in rat optic nerve. Kirsch M, Schneider T, Lee MY, Hofmann HD. Glia; 1998 Jul 02; 23(3):239-48. PubMed ID: 9633808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]